Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugsAymon, Romain (Avtor) Mongin, Denis (Avtor) Guemara, Romain (Avtor) Salis, Zubeyir (Avtor) Askling, Johan (Avtor) Choquette, Denis (Avtor) Codreanu, Catalin (Avtor) Di Giuseppe, Daniela (Avtor) Flouri, Irini (Avtor) Huschek, Doreen (Avtor) Rotar, Žiga (Avtor) adverse cardiovascular eventsrheumatoid arthritispatientsJanus kinase inhibitorsbiologic disease-modifying antirheumatic drugs"JAK-pot" study20252026-02-27 09:47:35Neznano27900UDK: 616-002ISSN pri članku: 2326-5191DOI: 10.1002/art.43188COBISS_ID: 234984707sl